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relevant depressive symptoms (CRDS, defined by a BDI-
score  ≥ 18) the self-reporting Beck Depression Inventory 
(BDI) was obtained on inclusion in the study. Associations 
with baseline parameters, stroke severity (National Institutes 
of Health Stroke Scale, NIHSS), and brain MRI findings were 
analyzed.  Results: From the 2007 patients with BDI docu-
mentation, 202 (10.1%) had CRDS. CRDS were observed 
more frequently in women (12.6 vs. 8.2% in men, p < 0.001). 
Patients with CRDS more often had arterial hypertension, di-
abetes mellitus, and hyperlipidemia than patients without 
CRDS (hypertension: 58.0 vs. 47.1%, p = 0.017; diabetes mel-
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 Abstract 
 Background: Although post-stroke depression is widely rec-
ognized, less is known about depressive symptoms in the 
acute stage of stroke and especially in young stroke patients. 
We thus investigated depressive symptoms and their deter-
minants in such a cohort.  Methods: The Stroke in Young Fab-
ry Patients study (sifap1) prospectively recruited a large mul-
tinational European cohort (n = 5,023) of patients with a 
cerebrovascular event aged 18–55. For assessing clinically 
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litus: 17.9 vs. 8.9%, p < 0.001; hyperlipidemia: 40.5 vs. 32.3%, 
p = 0.012). In the subgroup of patients with ischemic stroke 
or TIA (n = 1,832) no significant associations between CRDS 
and cerebral MRI findings such as the presence of acute in-
farcts (68.1  vs. 65.8%, p = 0.666), old infarctions (63.4 vs. 
62.1%, p = 0.725) or white matter hyper-intensities (51.6 vs. 
53.7%, p = 0.520) were found.  Conclusion: Depressive symp-
toms were present in 10.1% of young stroke patients in the 
acute phase, and were related to risk factors but not to imag-
ing findings.  © 2015 S. Karger AG, Basel 
 Introduction 
 As a disabling disease, stroke has an enormous emo-
tional impact  [1, 2] . In this context, depression is an im-
portant consequence, which influences stroke recovery 
 [1, 3–5] . Most of the studies on mood disorders were con-
ducted in general stroke populations without focusing on 
young patients, although in those, depression is particu-
larly relevant with impact on the social and occupational 
re-integration  [5, 6] . Recently, several studies on young 
stroke provided important information on age and gen-
der distribution, risk factors, etiologic factors, and imag-
ing findings  [7, 8] . However, data on mood disorders 
such as depression in this specific group are limited. In-
vestigating the occurrence, distribution, clinical and im-
aging correlates of depressive symptoms in young stroke 
patients is important, as depression has severe conse-
quences in terms of its impact on stroke recovery.
 We therefore investigated depressive symptoms and 
potential determinants in acute young stroke patients 
 included in the Stroke in Young Fabry Patients study 
 (sifap1), a large multicentre European study on young 
stroke  [8] .
 Methods 
 Design of the Study 
 The multinational sifap1 study (47 centers in 15 European 
countries) prospectively recruited (between April 2007 and 
 January 2010) 5,023 patients aged 18–55 with a cerebrovascular 
event (CVE) to establish the prevalence of Fabry disease. Details of 
this study have been published previously  [8] . The study was ap-
proved by the Ethics committees at the leading center and each 
study site. All patients or their legal representatives gave written 
informed consent. Inclusion criteria were CVE <3 months, age 
18–55 years, and cerebral MRI obtained within  ≤ 1 month of inclu-
sion. Diagnostic procedures were in accordance with the European 
Stroke Organisation Guidelines  [9] .
 A secondary aim of the sifap1 study was to better characterize 
the pattern of stroke in young patients collecting a broad range 
of clinical, laboratory, and radiological data using mandatory 
stringent standardized methods. The present secondary analysis 
aimed to investigate clinically relevant depressive symptoms 
(CRDS) and potential determinants such as demographics, risk 
factors, stroke severity, and imaging findings. CRDS were as-
sessed on inclusion in the study with the Beck Depression Inven-
tory (BDI). 
 Baseline Characteristics 
 A transient ischemic attack (TIA) was defined as a CVE with 
clinical symptoms lasting <24 h. Ischemic stroke subtypes were 
classified according to the published criteria in the Trial of Org 
10172 in Acute Stroke Treatment (TOAST)  [10] . Using informa-
tion from medical history and concomitant medications we con-
sidered the following risk factors: diabetes, arterial hypertension, 
dyslipidemia, and cardiovascular disease (history of coronary ar-
tery, peripheral arterial or congestive heart disease, prior myocar-
dial infarction, and/or valvular disease). Hypertension and dyslip-
idemia were defined according to national guidelines used at each 
study center. Anthropometric measurements (height, body weight 
in kilogram) obtained at study inclusion were used to calculate 
obesity according to body mass index (BMI  ≥ 30). Details of further 
lifestyle risk factors were based on patients’ self-report and stan-
dardized questionnaires. Tobacco use was considered in the case 
of those who were currently smoking or those who had quit smok-
ing in the last 5 years. Regular drinking was defined as a consump-
tion of at least one drink/week; higher consumption referred to 
more than five drinks a day at least once a month. Severity of stroke 
(NIHSS) was assessed within the first 48 h or at the time of maxi-
mal impairment. Short night sleep duration was defined as sleep-
ing  ≤ 6 at night time per 24 h. Physical inactivity was defined as 
walking less than 1 mile per day. Demographics (age, sex, and eth-
nicity) were included in the mandatory core data set collected by 
centers.
 Beck Depression Inventory 
 The BDI is a 21-question multiple-choice self-reported ques-
tionnaire to measure the degree of depressive symptoms  [11] . Each 
item has a set of four potential answer options, ranging in inten-
sity. The score ranges from 0 to 63; scores of 18 or higher indicate 
CRDS  [2, 11] . The assessment was performed on inclusion in the 
study and was an optional procedure. 
 Cerebral Magnetic Resonance Imaging (MRI) 
 Cerebral MRI was mandatory for all study participants. Stan-
dardized MRI sequences were required by protocol (at least T2-
weighted and/or fluid-attenuated inversion recovery images and 
diffusion-weighted imaging sequences)  [12] . All MR images were 
analyzed offline centrally by experienced readers blinded to clini-
cal and demographic data (C.E., F.F., R.S.). For ischemic infarcts 
they noted infarct type and number, infarct location, size, and 
vascular territories involved by using the templates by Tatu et al. 
 [12] . DWI sequences served to identify areas of acute ischemia 
 [12, 13] . Old infarcts were defined as areas of T2 hyperintensity 
with associated focal atrophy and/or containing fluid-filled spac-
es  [12] . White matter hyperintensities (WMHs) were defined as 
lesions with high signal intensity on T2-weighted images in the 
absence of evidence for complete tissue destruction and were rat-
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ed according to the Fazekas scale  [12] . Deep WMHs were classi-
fied as 0 = absent, 1 = punctuate, 2 = early confluent, and 3 = con-
fluent; periventricular white matter hyperintensities (PWMH) 
were stratified into: 0 = absent; 1 = pencil-thin lining; 2 = halo of 
 ≥ 5 mm thickness; 3 = irregular WMH extending into deep white 
matter  [12] . The total number and location of microbleeds (de-
fined on gradient-echo T2 * -weighted images as areas of signal loss 
within the brain parenchyma not exceeding 5 mm in diameter) 
were recorded  [12] .
 Statistical Analyses 
 First, descriptive analyses were conducted. Univariate analysis 
was established to test associations of several characteristics with 
CRDS. For the subgroup of patients with ischemic stroke and TIA, 
separate univariate analyses for men and women for the associa-
tion between characteristics (including MRI findings) and CRDS 
were calculated. 
 A multiple logistics regression was conducted to test which 
characteristics were associated with CRDS in ischemic stroke and 
TIA patients after adjustment for other covariates. Only covariates 
with significant associations in univariate analyses were selected 
for the multiple regression models. All p values were adjusted for 
center heterogeneity by using random effects models. A p value of 
<0.05 was considered statistically significant. No adjustment for 
multiple testing was applied. All statistical analyses were conduct-
ed using IBM © SPSS © Statistics 22 ( © SPSS Inc., IBM Company, 
2013, Chicago, Ill., USA) and SAS 9.3 ( © 2010 SAS Institute Inc., 
Cary, N.C., USA).
 Results 
 We obtained a BDI in 2007 from a total of 5,023 pa-
tients; 1,832 patients had an ischemic stroke or TIA and 
100 patients had a primary hemorrhage; in 36 patients no 
stroke entity was documented, in further 39 other causes 
for stroke (e.g., cerebral vein thrombosis) were found. 
The comparison of patients with a BDI assessment versus 
those without a BDI assessment revealed no relevant dif-
ferences in the proportions of diabetes and hypertension; 
patients with a BDI assessment were slightly younger 
(median 46 vs. 47 years, p = 0.031) and were less severely 
affected (NIHSS median 2 vs. 3, p = 0.001). Furthermore, 
a BDI assessment was obtained more often in patients 
with TIA, and less often in those with primary intracere-
bral hemorrhage and ischemic stroke ( table 1 ).
 The BDI score for the investigated population ranged 
from 0 to 47 (interquartile range: 1–11) with a median of 
five. The median delay for the BDI assessment was five 
days after admission (interquartile range 1–11 days). 
Overall, CRDS were present in 202 patients (10.1%); they 
occurred more often in female than in male patients 
(12.6  vs. 8.2%, p < 0.001). With increasing age, higher 
proportions of patients with CRDS were detected ( fig. 1 ). 
While stroke severity was similar, patients with CRDS 
had more often arterial hypertension, diabetes mellitus, 
and dyslipidemia than patients without CRDS (hyperten-
sion: 58.0 vs. 47.1%, p = 0.017; diabetes mellitus: 17.9 vs. 
8.9%, p < 0.001; dyslipidaemia: 40.5 vs. 32.3%, p = 0.012) 
( table 2 ). 
Table 1.  Comparison of young stroke patients with BDI-assess-
ment versus those without
Total 
cohort 
(n = 5,023)
BDI 
assessment 
(n = 2,007)
No BDI 
assessment 
(n = 3,016)
p
Sex, %
Male 59.0 57.3 60.0 0.391
Age median (IQR) 46 (40–51) 46 (41–51) 47 (40–51) 0.031
Stroke entity (n = 4,806), %
TIA 22.3 26.2 19.6 0.004
Ischemic stroke 70.7 66.8 73.4
Primary hemorrhage 5.6 5.1 6.0
Other 1.4 2.0 1.0
Stroke severity (n = 5,022)
NIHSS median (IQR) 3 (1–6) 2 (1–5) 3 (1–6) 0.001
Risk factors, %
Hypertension 
(n = 4,994) 47.0 48.2 46.2 0.054
Diabetes mellitus 
(n = 4,996) 10.0 9.8 10.2 0.224
 BDI = Beck depression inventory; IQR = interquartile range; TIA = tran-
sient ischemic attack; NIHSS = National institute of Health Stroke Scale.
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 Fig. 1. Proportions of patients with clinically relevant depressive 
symptoms (CRDS) among different age classes. Percentages of pa-
tients with CRDS are indicated on each column. 
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 In the subgroup of patients with ischemic stroke or TIA 
(n = 1,832), CRDS also occurred more frequently in fe-
males (11.8 vs. 8.3%, p = 0.014). The results of the analysis 
conducted within this group of patients (with stroke or 
TIA) is presented in  tables 3 and  4 . In both sexes, those 
with CRDS had more often a CVE caused by large artery 
atherosclerosis (male: 29.4 vs. 19.3%;  female: 17.6 vs. 
11.8%) but less often caused by cardioembolic strokes 
(male: 7.1 vs. 15.2%; female: 13.2 vs. 16.1%), ( table 3 ). The 
presence of vascular risk factors including hypertension, 
diabetes mellitus and hyperlipidemia was associated with 
the occurrence of CRDS in both sexes ( table 3 ). 
Table 2.  Baseline characteristics in young stroke patients with depressive symptoms
Total cohort 
(n = 2,007)
No or mild depressive 
symptoms
BDI <18 (n = 1,805)
Clinically relevant 
depressive symptoms 
BDI ≥18 (n = 202)
p
Sex, n (%)
Male 1,151 (57.3) 1,057 (58.6) 94 (46.5) <0.001
Age, n (%)
18–24 years 59 (2.9) 57 (3.2) 2 (1.0) 0.024
25–34 years 190 (9.5) 176 (9.8) 14 (6.9)
35–44 years 552 (27.5) 500 (27.7) 52 (25.7)
45–55 years 1,206 (60.1) 1,072 (59.4) 134 (66.3)
Time delay admission to BDI, n (%) (n = 1,727) (n = 1,545) (n = 182)
≤7 days 1,160 (67.2) 1,048 (67.8) 112 (61.5) 0.558 
8–14 days 312 (18.1) 273 (17.7) 39 (21.4)
15–28 days 129 (7.5) 114 (7.4) 15 (8.2)
>28 days 126 (7.3) 110 (7.1) 16 (8.8)
Time delay stroke onset to BDI, n (%) (n = 1,603) (n = 1,438) (n = 165)
≤7 days 1,092 (68.1) 987 (68.6) 105 (63.6) 0.672
8–14 days 279 (17.4) 245 (17.0) 34 (20.6)
15–28 days 118 (7.4) 104 (7.2) 14 (8.5)
>28 days 114 (7.1) 102 (7.1) 12 (7.3)
Stroke entity, n (%) (n = 1,971) (n = 1,771) (n = 200)
TIA 516 (26.2) 461 (26.0) 55 (27.5) 0.568
Ischemic stroke 1,316 (66.8) 1,192 (67.3) 124 (62.0)
Primary hemorrhage 100 (5.1) 84 (4.7) 16 (8.0)
Other 39 (2.0) 34 (1.9) 5 (2.5)
Stroke severity (n = 2,007)
NIHSS median (IQR) 2 (1–5) 2 (1–5) 3 (1–6) 0.130
In males (n = 1,151) 3 (1–5) 3 (1–5) 3 (1–7) 0.106
In females (n = 856) 2 (1–5) 2 (1–4) 3 (1–6) 0.390
Risk factors, n (%)
Hypertension (n = 1,995) 961 (48.2) 845 (47.1) 116 (58.0) 0.017
Diabetes mellitus (n = 1,996) 195 (9.8) 159 (8.9) 36 (17.9) <0.001
Hyperlipidemia (n = 1,922) 637 (33.1) 560 (32.3) 77 (40.5) 0.012
Obesity (BMI ≥30 kg/m2) (n = 2,007) 459 (22.9) 405 (22.4) 54 (26.7) 0.082
Tobacco smoking* (n = 1,992) 1,103 (55.4) 993 (55.4) 110 (55.0) 0.925
Cardiovascular disease** (n = 1,962) 165 (8.4) 148 (8.4) 17 (8.7) 0.980
Physical inactivity*** (n = 1,938) 924 (47.7) 819 (47.0) 105 (54.1) 0.080
Obstructive sleep apnea (n = 1,970) 72 (3.7) 63 (3.6) 9 (4.5) 0.395
Sleep ≤6 h at night time (n = 2,006) 367 (18.3) 339 (18.8) 28 (13.9) 0.052
Regular alcohol consumption† (n = 1,997) 1,017 (50.9) 924 (51.4) 93 (46.5) 0.434
Higher alcohol consumption‡ (n = 1,949) 650 (33.4) 589 (33.6) 61 (31.3) 0.375
 * Current smoking or quit within last 5 years. ** Cardiovascular disease considers one of the following conditions: ischemic coronary 
artery disease, myocardial infarctions, peripheral artery occlusive disease, congestive heart failure and valvular disease. *** <1 mile per 
day walking. † Consumption of at least one drink/week. ‡ 5 drinks a day at least once a month. BDI= Beck depression inventory; IQR= 
interquartile range; TIA = transient ischemic attack; NIHSS = National Institute of Health Stroke Scale.
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 Out of 1,832 patients with ischemic stroke or TIA, 1,730 
patients had a cerebral MRI. No specific brain imaging 
findings were associated with the occurrence of CRDS ( ta-
ble  4 ). In CRDS patients, white matter hyperintensities 
(WMH) were not more frequent in patients with CRDS 
versus those without (deep WMH as well as periventricular 
WMH) (male: 47.4 vs. 47.3%, p = 0.734; female: 49.4 vs. 
44.9%, p = 0.575) ( table 4 ); even after stratifying WMH ac-
cording to their severity no relevant differences between 
patients with versus without CRDS were noted ( table 4 ). 
Table 3.  Differences in baseline characteristics between patients with no or mild depressive symptoms versus with clinically relevant 
depressive symptoms in the subgroup of patients with ischemic stroke or TIA by sex
n  Males p Females p
no or mild 
depressive 
symptoms 
(BDI <18)
clinically rel. 
depressive 
symptoms 
(BDI ≥18)
no or mild 
depressive 
symptoms 
(BDI <18)
clinically rel. 
depressive 
symptoms 
(BDI ≥18)
 Ischemic stroke or TIA 1,832 967 87 – 686 92 –
TIA, n (%) 516 (28.2) 252 (26.1) 20 (23.0) 0.482 209 (30.5) 35 (38.0) 0.106
Age median (IQR), % 46 (41–51) 47 (42–52) 47 (43–53) 0.037 45 (39–49) 48 (42–51) 0.022
18–24 years 53 (2.9) 19 (2.0) – 32 (4.7) 2 (2.2)
25–34 years 174 (9.5) 75 (7.8) 2 (2.3) 88 (12.8) 9 (9.8)
35–44 years 503 (27.5) 262 (27.1) 25 (28.7) 195 (28.4) 21 (22.8)
45–55 years 1,102 (60.2) 611 (63.2) 60 (69.0) 371 (54.1) 60 (65.2)
Stroke etiology (n = 1,781), n (%)
Large artery atherosclerosis 301 (16.9) 182 (19.3) 25 (29.4) 0.005 78 (11.8) 16 (17.6) 0.078
Cardioembolism 268 (15.0) 143 (15.2) 6 (7.1) 107 (16.1) 12 (13.2)
Small vessel disease 292 (16.4) 179 (19.0) 18 (21.2) 80 (12.1) 15 (16.5)
Other determined etiology 286 (16.1) 129 (13.7) 9 (10.6) 129 (19.5) 19 (20.9)
Undetermined etiology 634 (35.6) 309 (32.8) 27 (31.8) 269 (40.6) 29 (31.9)
Risk factors, n (%)
Hypertension (n = 1,820) 869 (47.7) 507 (52.9) 58 (66.7) 0.029 259 (37.8) 45 (50.0) 0.031
Diabetes mellitus (n = 1,822) 182 (10.0) 114 (11.9) 23 (26.7) <0.001 34 (5.0) 11 (12.0) <0.001
Hyperlipidemia (n = 1,761) 599 (34.0) 348 (37.7) 40 (47.6) 0.068 179 (26.8) 32 (37.2) 0.044
Tobacco smoking* (n = 1,817) 1,023 (56.3) 573 (59.9) 52 (60.5) 0.995 350 (51.2) 48 (52.7) 0.717
Obesity (BMI ≥30 kg/m2) 
(n = 1,832) 429 (23.4) 234 (24.2) 25 (28.7) 0.232 145 (21.1) 25 (27.2) 0.147
Cardiovascular disease** 
(n = 1,790) 148 (8.3) 91 (9.7) 8 (9.4) 0.816 43 (6.3) 6 (6.9) 0.820
Obstructive sleep apnea 
(n = 1,799) 71 (3.9) 52 (5.5) 5 (6.0) 0.055 10 (1.5) 4 (4.4) 0.820
Physical activity (n = 1,770)
Walking <1 mile/day 836 (47.2) 436 (46.4) 42 (51.2) 0.603 306 (46.4) 52 (57.8) 0.230
20–30 min, 3 times/week 539 (30.5) 288 (30.7) 23 (28.0) 206 (31.3) 22 (24.4)
>30 min, >3 times/week 33 (19.2) 215 (22.9) 17 (20.7) 147 (22.3) 16 (17.8)
Night sleep (n = 1,831)
≤6 h/24 h 342 (18.7) 222 (23.0) 12 (13.8) 0.129 95 (13.8) 13 (14.1) 0.625
>6–9 h/24 h 1,123 (61.3) 584 (60.5) 58 (66.7) 428 (62.4) 53 (57.6)
≥9 h/24 h 366 (20.0) 160 (16.6) 17 (19.5) 163 (23.8) 26 (28.3)
Regular alcohol consumption 
(n = 1,824), n (%) 925 (50.7) 593 (61.6) 52 (61.2) 0.884 246 (35.9) 34 (37.0) 0.756
Higher alcohol consumption 
(n = 1,779), n (%) 590 (33.2) 392 (42.0) 34 (41.5) 0.915 142 (21.1) 22 (24.4) 0.649
Stroke severity, median (IQR)
NIHSS 2 (1–5) 2 (1–5) 3 (1–6) 0.080 2 (1–4) 3 (1–5) 0.803
 * Current smoking or quit within last 5 years. ** Cardiovascular disease considers one of the following conditions: ischemic coronary 
artery disease, myocardial infarctions, peripheral artery occlusive disease, congestive heart failure and valvular disease. † Consumption of 
at least one drink/week. ‡ 5 drinks a day at least once a month. BDI = Beck depression inventory; IQR = interquartile range; TIA = transient 
ischaemic attack; NIHSS = National Institute of Health Stroke Scale.
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Table 4.  Brain imaging findings between patients with no or mild depressive symptoms versus with clinically relevant depressive symp-
toms in the subgroup of patients with ischemic stroke or TIA by sex
n Males p  Females p
no or mild 
depressive 
symptoms 
(BDI <18)
clinically relevant 
depressive 
symptoms 
(BDI ≥18)
no o r mild 
depressive 
symptoms 
(BDI <18)
clinically relevant 
depressive 
symptoms 
(BDI ≥18)
Ischemic stroke or TIA with brain imaging 1,730 917 81 647 85
Acute infarct, n (%)
≥1 acute lesion 1,142 (66.0) 628 (68.5) 61 (75.3) 0.249 401 (62.0) 52 (61.2) 0.918
Left hemispheric (n = 1,709) 473 (27.7) 259 (28.6) 25 (31.3) 0.653 169 (26.4) 20 (24.1) 0.674
Right hemispheric (n = 1,709) 429 (25.1) 243 (26.8) 23 (28.8) 0.639 144 (22.5) 19 (22.9) 0.957
Vascular territory
Arteria cerebri anterior 51 (2.9) 25 (2.7) 3 (3.7) 0.720 17 (2.6) 6 (7.1) 0.030
Arteria cerebri media 651 (37.6) 344 (37.5) 35 (43.2) 0.351 238 (36.8) 34 (40.0) 0.473
Arteria cerebri posterior 145 (8.4) 85 (9.3) 6 (7.4) 0.611 49 (7.6) 5 (5.9) 0.565
Vertebrobasilar 250 (14.5) 158 (17.2) 16 (19.8) 0.537 67 (10.4) 9 (10.6) 0.971
Infarct type
Territorial 759 (43.9) 415 (45.3) 37 (45.7) 0.930 275 (42.5) 32 (37.6) 0.280
Watershed 54 (3.1) 21 (2.3) 7 (8.6) 0.005 22 (3.4) 4 (4.7) 0.471
Lacunar 230 (13.3) 142 (15.5) 14 (17.3) 0.650 62 (9.6) 12 (14.1) 0.214
Infarct size
<1 cm 481 (26.8) 271 (29.6) 27 (33.3) 0.521 158 (24.4) 25 (29.4) 0.325
≤ half of a lobe 568 (31.7) 302 (32.9) 30 (37.0) 0.472 212 (32.8) 24 (28.2) 0.379
> half of a lobe 90 (5.0) 53 (5.8) 6 (7.4) 0.475 26 (4.0) 5 (5.9) 0.483
Old infarct, n (%)
≥1 old infarct 428 (37.7) 247 (39.5) 22 (36.1) 0.533 140 (35.3) 19 (37.3) 0.788
Left hemispheric 147 (8.5) 89 (9.7) 5 (6.2) 0.200 46 (7.1) 7 (8.2) 0.696
Right hemispheric 110 (6.4) 61 (6.7) 6 (7.4) 0.782 41 (6.3) 2 (2.4) 0.126
Vascular territory
Arteria cerebri anterior 21 (1.2) 13 (1.4) 1 (1.2) 0.889 7 (1.1) – 0.995
Arteria cerebri media 314 (18.2) 179 (19.5) 18 (22.2) 0.485 101 (15.6) 16 (18.8) 0.323
Arteria cerebri posterior 83 (4.8) 48 (5.2) 3 (3.7) 0.531 25 (3.9) 7 (8.2) 0.023
Vertebrobasilar 157 (9.1) 89 (9.7) 7 (8.6) 0.706 53 (8.2) 8 (9.4) 0.712
Infarct type
Territorial 217 (12.5) 119 (13.0) 11 (13.6) 0.912 79 (12.2) 8 (9.4) 0.451
Watershed 45 (2.6) 24 (2.6) 1 (1.2) 0.371 19 (2.9) 1 (1.2) 0.380
Lacunar 223 (12.9) 136 (14.8) 12 (14.8) 0.944 62 (9.6) 13 (15.3) 0.121
Infarct size
<1 cm 295 (16.5) 172 (18.8) 16 (19.8) 0.846 94 (14.5) 13 (15.3) 0.826
≤ half of a lobe 168 (9.4) 87 (9.5) 8 (9.9) 0.861 65 (10.0) 8 (9.4) 0.874
> half of a lobe 13 (0.7) 7 (0.8) 2 (2.5) 0.122 3 (0.5) 1 (1.2) 0.370
Deep WMH (n = 1,604), n (%)
0 930 (58.0) 485 (57.3) 45 (59.2) 0.946 358 (59.4) 42 (53.2) 0.168
1 490 (30.5) 257 (30.4) 21 (27.6) 188 (31.2) 24 (30.4)
2 116 (7.2) 68 (8.0) 7 (9.2) 33 (5.5) 8 (10.1)
3 68 (4.2) 36 (4.3) 3 (3.9) 24 (4.0) 5 (6.3)
Periventricular WMH (n = 1,603), n (%)
0 1,174 (73.2) 601 (71.1) 58 (76.3) 0.301 461 (76.5) 54 (68.4) 0.095
1 309 (19.3) 167 (19.8) 14 (18.4) 110 (18.2) 18 (22.8)
2 66 (4.1) 43 (5.1) 3 (3.9) 15 (2.5) 5 (6.3)
3 54 (3.4) 34 (4.0) 1 (1.3) 17 (2.8) 2 (2.5)
WMH at all (n = 1,603), n (%) 746 (46.5) 400 (47.3) 36 (47.4) 0.734 271 (44.9) 39 (49.4) 0.575
Microbleeds (n = 714), n (%)
0 671 (94.0) 339 (93.4) 37 (100) <0.001 260 (94.2) 35 (92.1) 0.684
1–3 27 (3.8) 16 (4.4) – 9 (3.3) 2 (5.3)
≥4 16 (2.2) 8 (2.2) – 7 (2.5) 1 (2.6)
 BDI = Beck depression inventory; TIA = transient ischaemic attack; WMH = white matter hyperintensities.
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 In the logistic regression analysis after adjusting for 
other relevant covariates female sex (OR 1.81, 95% CI 
1.32–2.49) and diabetes mellitus (OR 2.04, 95% CI 1.46–
2.86) were associated with CRDS ( table 5 ).
 Discussion 
 In this specific group of acute young strokes (18–55 
years), we found 10.1% harboring CRDS in the early stage 
of their disease. The occurrence of CRDS was associated 
with the female sex and the presence of diabetes mellitus. 
Stroke severity and brain MRI lesion characteristics did 
not affect the occurrence of CRDS.
 To view our results in an appropriate context and 
compare them with other investigations on depression in 
the acute phase of stroke, different aspects need to be con-
sidered: studies investigating mood disorders included 
patients mainly without age restriction and the defini-
tions of disorders, instruments and the time intervals for 
the assessment differed widely  [14] . In the sifap1 study 
depressiveness was assessed in the early stage of stroke 
(median 5 days after admission). For comparison few in-
vestigations in acute hospitalized strokes are available. In 
such studies relevant depressive symptoms were reported 
in 12–14% of the patients  [15–17] . Hence, the rate of 
CRDS depicted in sifap1 (10.1%) is comparable to these 
results especially when considering that we examined a 
cohort of young strokes. 
 It needs to be considered, however, that a substantial 
proportion of patients seem to develop CRDS beyond 
the acute phase. In the FINNSTROKE study, BDI-values 
>18 were found in 24% of the patients at three months 
after the CVE; one year later the proportion rose to 30%. 
The obviously small proportion of depressed stroke pa-
tients in the acute stage and the high depression inci-
dence within the first year render specific therapeutic 
measurements necessary, with potential benefit in avoid-
ing this complication. Especially in young stroke, this 
approach deserves more attention in the rehabilitation 
process. Positive effects in recovery could be expected, 
allowing potentially quicker social and occupational re-
integration and in particular the restart of professional 
activities.
 In our study, females with acute stroke suffered more 
often from CRDS than males. This finding was also de-
picted in previous studies conducted in general stroke 
populations  [2, 18–20] . As an explanation, the authors 
speculated that many stroke patients are older women 
 living alone  [2, 19, 20] . In sifap1 young stroke patients 
were recruited; thus, our results cannot be explained by 
loneliness of older women. Other mechanisms such as 
genetic predisposition, fluctuating hormone levels in 
women or direct psychological issues such as coping with 
traumatic events appear to be more relevant  [21–23] . Fac-
ing the high psychological impact related to a CVE, sex-
specific coping strategies could be relevant for explaining 
sex differences regarding CRDS in our patients. The ten-
dency for developing depressive symptoms after stroke 
more often in older ages could also be observed in our 
study  [18] . In both sexes, the oldest age group of 45–55 
years exhibited the largest proportion of patients with 
CRDS.
 The relationship between WMH and mood disorders 
is contradictory. While some authors suggest WMH may 
play a role in the development of mood disorders, others 
report no association between WMH and depressive 
symptoms  [24–29] . When dealing with stroke patients, 
no relation between post-stroke depressive symptoms 
and pre-existing WMH in the brain could be ascertained 
 [26, 29, 30] . An association of WMH and delayed mood 
disorders after stroke has been described, but no rele-
vance for the development of depressive symptoms in the 
acute stage  [16, 30] has been found . Accordingly, our 
findings are in line with these findings; in our study, 
WMH (at all or stratified by severity) were not associated 
with the occurrence of CRDS. Acute ischemic lesions 
were also not associated with CRDS, in contrast to inves-
tigations claiming a relevance of lesion’s location such as 
the affected region  [26, 30] . Overall, our findings suggest 
that in young stroke patients, depressive symptoms in the 
Table 5.  Multiple logistic regression for clinically relevant depres-
sive symptoms (BDI ≥18) in those patients with ischemic stroke or 
TIA (n = 1,701, 41 centers) (mixed model with random intercept)
OR (95% CI) p
Fixed effects
Sex 1.81 (1.32–2.49) 0.001
Age (in decades) 1.28 (0.98–1.67) 0.072
Diabetes 2.04 (1.46–2.86) <0.001
Hypertension 1.27 (0.83–1.93) 0.271
Hyperlipidemia 1.12 (0.80–1.55) 0.521
Stroke etiology (reference: undetermined etiology)
Arteriosclerotic 1.53 (1.00–2.32) 0.066
Cardioembolism 0.78 (0.51–1.18)
Small vessel 1.13 (0.79–1.61)
Other determined 1.21 (0.75–1.94)
Random effects
Between centre variance 0.29 (0.11) <0.001
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acute stage are rather related to a psychological reactive 
phenomenon to the event itself than to pre-existing or 
acute lesions of the brain.
 Scarce evidence exists indicating the association of 
vascular risk factors with the occurrence of depression 
after stroke  [25, 31] . The multiple logistic regression anal-
ysis in the subgroup of patients with ischemic stroke or 
TIA showed that apart from sex diabetes mellitus there 
remained an independent parameter associated with 
CRDS after controlling for other relevant characteristics. 
In this context, stroke subtypes favored by vascular risk 
factors did not emerge as independent factors. The rea-
sons for the association of diabetes mellitus and depres-
sion after stroke remain unclear, albeit differences in cog-
nitive performance could play a role. This hypothesis 
arises from recent studies showing that diabetes might 
independently determine cognitive decline in vascular 
patients  [32] .
 In our study, depressive symptoms were investigated 
with a validated standard tool for assessing CRDS, but no 
cognition assessments were provided. This is one of the 
main limitations of the present investigation; in several 
investigations, the cognitive status featured as a main de-
terminant for depressive symptoms irrespective of cur-
rent circumstances. A further limitation represents the 
lack of a direct control group for comparison. Sifap1 was 
designed for establishing the prevalence of Fabry disease 
in an unselected population of young stroke patients; thus 
a cross-sectional investigation was the appropriate choice. 
However, data derived from case control studies suggest 
that CRDS in young healthy individuals are less frequent 
than in sifap1  [33–36] . As the BDI-assessment was an op-
tional item within the study, it was not done in all study 
participants. In this context, the selection bias of exclu-
sion of patients more severely affected by stroke form 
BDI assessment needs to be considered when interpreting 
our results, whereas there was no such bias with regard to 
sex. The BDI is a self-reporting assessment for investigat-
ing depressive symptoms. Even validated for the utiliza-
tion in this manner, a verification of the diagnosis in a 
direct consultation or examination by specialists was not 
allocated. This might represent another limitation espe-
cially among patients with low scores in the BDI assess-
ment.
 Conclusion 
 In summary, we detected CRDS in 10.1% of young 
acute stroke patients early after the event. Parameters 
such as characteristics of acute lesions or the presence of 
WMH were not associated with the presence of CRDS. 
Diabetes mellitus was the most important parameter as-
sociated with CRDS. In female patients, CRDS occurred 
more often as compared to male individuals, probably 
due to different strategies in coping with traumatic events. 
Further investigations in young strokes are required to 
prove the long-term follow up of CRDS. This is especial-
ly of interest for the development of tailored treatment 
strategies for the rehabilitation, potentially beneficial for 
the recovery process.
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